BioSpace News Archive

Economic turbulence has persisted into 2023 and the life science industry is certainly not immune. How are organizations juggling business needs, budgets, recruitment and retention?

BioSpace is exploring PTO trends and federal holidays granted to life sciences professionals.

Following a tumultuous start to 2023, layoffs have cooled off though recruiting activities have been significantly impacted by the economic environment.

SAB Biotherapeutics today reported financial results for the second quarter ended June 30, 2023, and provided a company update.

Eilean Therapeutics LLC today announced the initiation of human dosing in the Phase 1 clinical program of ZE46-0134, a highly potent and selective pan-FLT3 inhibitor that targets clinically relevant FLT3 mutations including the FLT3 gatekeeper mutation, while sparing the wild type form of the protein.

Inhibikase Therapeutics, Inc. is evaluating new molecules with multiple mechanisms of action for c-Abl inhibition.

Enzymit, a specialty biochemical company developing cell-free enzymatic manufacturing technology, today announced the publication of a new study published on bioRxiv demonstrating the efficacy of its deep learning-based technology for novel enzyme design.

Boekel Scientific introduces a new product line that consists of 4 families of centrifuges: economy, general purpose, STAT, and Blood Bank.

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that analyses of clinical study results relating to INPEFA™ (sotagliflozin), its recently approved drug for heart failure, as well as Lexicon-supported data relating to changing patterns of heart failure diagnoses, will be highlighted in two sessions during ESC Congress 2023, taking place August 25-28, 2023, in Amsterdam, The Netherlands and online.

Mycovia Pharmaceuticals, Inc. today announced that Jiangsu Hengrui Pharmaceuticals Co., Ltd (“Hengrui”) received approval in June from the National Medical Products Administration for Oteseconazole Capsules, an azole antifungal, indicated for the treatment of severe vulvovaginal candidiasis (VVC).